Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3096 of 6351
-
Promising drug shows hope for rare skin condition
Disease control CompletedThe purpose of this study is to evaluate the safety and effectiveness of Deucravacitinib (BMS-986165) in Pityriasis Rubra Pilaris as assessed by the change in Investigator Global Assessment (IGA), PASI- 50, 75, 90, DLQI, NRS itch, and Skindex-16 at week 24. To predict responses t…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Text message workouts could ease strain on hearts of PAH patients
Symptom relief OngoingThe purpose of this study is to evaluate whether a home rehabilitation program for patients diagnosed with Pulmonary Arterial Hypertension (PAH) will decrease Cardiac Effort (number of heart beats used during 6-minute walk test/walk distance) and improve quality of life. Ultimate…
Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Can MS patients safely switch to a gentler drug?
Disease control Recruiting nowA multi-center pilot study to evaluate safety and efficacy of ozanimod as de-escalation therapy in clinically stable MS patients previously treated with anti-CD20 therapy.
Phase 4 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 26, 2026 17:32 UTC
-
Can eye drops save sight during ovarian cancer treatment?
Symptom relief OngoingThe purpose of this study is to evaluate the incidence rate and severity of prespecified mirvetuximab soravtansine (MIRV)-related ocular treatment-emergent adverse events (TEAEs) and assess prophylaxis strategies in all participants (symptomatic and asymptomatic) undergoing prosp…
Phase 2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
AI could spot diabetic eye disease in minutes
Diagnosis OngoingThis research study is being conducted to improve eye care by using artificial intelligence (AI) to make diabetic eye screenings faster and more accessible. AI technology mimics human decision-making, enabling computers and systems to analyze medication information. Specifically …
Sponsor: Centro De Salud La Comunidad De San Ysidro Inc DBA: San Ysidro Health • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
New headset therapy may reduce need for repeat eye surgeries in kids
Disease control CompletedIntermittent exotropia is difficult to treat. The mainstay of treatment involves surgery, and in one long-term study authors found that as many as 60% of IXT required at least one re-operation.Patching of the non-dominant eye has also been tested in a large, multi-center randomiz…
Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New cancer drug combo enters first human tests
Disease control Recruiting nowThe main goal of this first-in-human (FIH) study is to learn about the safety and dosing of GS-2121 when given alone or in combination with zimberelimab (ZIM) in participants with advanced solid tumors. The primary objectives of this study are: * To assess the safety and tolera…
Phase 1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New pill aims to keep narcolepsy patients awake during the day
Symptom relief CompletedThe purpose of this study is to measure the safety and decrease in sleepiness in subjects with narcolepsy type 2 (NT2) when taking ALKS 2680 tablets compared to placebo tablets.
Phase 2 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Can an AI chatbot cure your sleepless nights?
Symptom relief OngoingInsomnia is a common sleep problem, which affects 9.4-38.2% of youths worldwide. Youth insomnia is linked to mental health problems, leading to substantial health and economic burden. The project aims to conduct an assessor-blind, randomized controlled trial to evaluate the effic…
Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Could a simple buzz replace needles' fear? stanford tests vibrating device on 1,100 patients
Symptom relief CompletedThis pragmatic, randomized study seeks to evaluate the applications of a novel vibrating device for reducing pediatric anxiety and distress during vascular access procedures.
Sponsor: Stanford University • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Could a sleep drug curb stimulant cravings?
Symptom relief Recruiting nowThe purpose of this study is to determine the effects of suvorexant (SUVO), on sleep, stress, and drug craving during early abstinence from stimulants and to determine the effects of treatment (SUVO vs. treatment as usual (TAU)) on post-treatment (Days 13-30) residential program …
Phase 2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jun 26, 2026 14:13 UTC
-
Real-World study tests Benralizumab's impact on severe asthma control
Disease control Recruiting nowThis is a prospective, non-interventional, single-arm, multicenter study to investigate asthma control, and health-related quality of life (HRQL), lung function and asthma medication intake in severe eosinophilic asthma patients treated with benralizumab in a real-life setting in…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Blood clot boost for knee surgery: new trial aims to prevent arthritis
Disease control Recruiting nowLongitudinal meniscal tears are a type of meniscal injury characterized by a displaced fragment of the meniscus that flips over into the joint, often resembling a buckle or handle. These tears typically occur in the medial meniscus and are often associated with traumatic knee inj…
Sponsor: Ankara City Hospital Bilkent • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Leukemia drug repurposed to fight resistant lung cancer
Disease control Recruiting nowThis phase I trial is studying the safety, side effects, and best dose of gilteritinib in treating patients with stage IV ALK positive non-small cell lung cancer (NSCLC) who have progressed on other treatments. While there are many approved targeted drugs for ALK NSCLC, resistanc…
Phase 1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
App aims to ease chronic pain in underserved communities
Symptom relief Recruiting nowThe purpose of this study is to examine the feasibility of the dissemination of a cognitive-behavioral eHealth application (app) for pain self-management with Black and LGBTQ+ adults with high-impact chronic pain lasting at least 3 months and disrupting daily functioning (Impleme…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
One shot could ease knee pain for a year: new hydrogel tested
Symptom relief OngoingThis study is a prospective, monocentric, interventional post-market study evaluating the effects of a single intra-articular injection of Arthrosamid in patients with symptomatic knee osteoarthritis. Arthrosamid is a polyacrylamide hydrogel consisting of 97.5% sterile water and …
Sponsor: Medisch Centrum Latem • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Could this pill ease tummy troubles for kids with IBS-C?
Symptom relief CompletedThis is a randomized, double-blind, placebo-controlled dose-ranging study to assess the safety and efficacy of tenapanor for treatment of the IBS-C in pediatric patients 6 to less than 12 year old.
Phase 2 • Sponsor: Ardelyx • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Scientists hunt for metabolic clues to boost lung cancer immunotherapy
Knowledge-focused Recruiting nowProspective, biological, observational study involving the collection and use of samples from patients suffering from NSCLC lung cancer, aimed at comparing the molecular profile related to metabolism among subjects with response or resistance to checkpoint inhibitors immune syste…
Sponsor: Regina Elena Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Can a massage with essential oils make childbirth less painful and scary?
Symptom relief CompletedAim: This study aimed to evaluate the effects of Swedish massage combined with lavender and chamomile oils on childbirth outcomes during the first and second stages of labor. Materials and Methods: This randomized controlled experimental study was conducted with 90 pregnant wome…
Sponsor: Kutahya Health Sciences University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
A new tool aims to cut caregiver back injuries by teaching proper lifting technique
Knowledge-focused Recruiting nowAs of 2020, 53 million Americans provide unpaid care to an individual with a disability. One commonly performed activity of daily living (ADL) provided by informal caregivers is assisted transfers, which requires moving an individual from one surface to another. Approximately 94%…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC